gebhart/patrepeval huggingface dataset:
Risk factors in the development of stem cell therapy (2011)

Stem cell therapy holds the promise to treat degenerative diseases, cancer and repair of damaged tissues for which there are currently no or limited therapeutic options. The potential of stem cell therapies has long been recognised and the creation of induced pluripotent stem cells (iPSC) has boosted the stem cell field leading to increasing development and scientific knowledge. Despite the clinical potential of stem cell based medicinal products there are also potential and unanticipated risks. These risks deserve a thorough discussion within the perspective of current scientific knowledge and experience. Evaluation of potential risks should be a prerequisite step before clinical use of stem cell based medicinal products.The risk profile of stem cell based medicinal products depends on many risk factors, which include the type of stem cells, their differentiation status and proliferation capacity, the route of administration, the intended location, in vitro culture and/or other manipulation steps, irreversibility of treatment, need/possibility for concurrent tissue regeneration in case of irreversible tissue loss, and long-term survival of engrafted cells. Together these factors determine the risk profile associated with a stem cell based medicinal product. The identified risks (i.e. risks identified in clinical experience) or potential/theoretical risks (i.e. risks observed in animal studies) include tumour formation, unwanted immune responses and the transmission of adventitious agents.Currently, there is no clinical experience with pluripotent stem cells (i.e. embryonal stem cells and iPSC). Based on their characteristics of unlimited self-renewal and high proliferation rate the risks associated with a product containing these cells (e.g. risk on tumour formation) are considered high, if not perceived to be unacceptable. In contrast, the vast majority of small-sized clinical trials conducted with mesenchymal stem/stromal cells (MSC) in regenerative medicine applications has not reported major health concerns, suggesting that MSC therapies could be relatively safe. However, in some clinical trials serious adverse events have been reported, which emphasizes the need for additional knowledge, particularly with regard to biological mechanisms and long term safety.
Folate Receptor‐Mediated Gene Delivery Using Folate‐Poly(ethylene glycol)‐Poly(L‐lysine) Conjugate (2005)

For efficient receptor-mediated gene transfection, a new and simple formulation method based on using PEI and FOLPEGPLL conjugate was presented. Luciferase plasmid DNA and PEI were complexed to form slightly positive-charged nanoparticles, onto which FOL-PEG-PLL conjugate was surface coated. With increasing the coating amount of FOL-PEG-PLL conjugate, the FOL-PEG-PLL/PEI/DNA complexes exhibited increased surface zeta-potential values with concomitantly increased diameters, indicating that the PLL part was physically anchored on the surface of preformed PEI/DNA complexes with FOL moieties being exposed on the outside. The formulated complexes exhibited a considerably higher transfection efficiency against FOL receptor over-expressing KB cells than FOL receptor deficient A549 cells. This was caused by an enhanced cellular uptake of the resultant complexes via a receptor-mediated endocytosis process. The formulated complexes showed a higher gene expression level, even in the presence of serum, than the PEI/DNA or Lipofectamine/DNA complexes. This was attributed to the PEG chains present on the surface of complexes that could work as a protective shield layer against aggregation caused by non-specific protein adsorption. The FOL-PEG-PLL/PEI/DNA complexes also demonstrated better cell viability than the PEI/DNA complexes.(1)H NMR spectrum of FOL-PEG-PLL conjugate.
High-Efficiency Broadband Meta-Hologram with Polarization-Controlled Dual Images (2013)

Holograms, the optical devices to reconstruct predesigned images, show many applications in our daily life. However, applications of hologram are still limited by the constituent materials and therefore their working range is trapped at a particular electromagnetic region. In recent years, the metasurfaces, an array of subwavelength antenna with varying sizes, show the abilities to manipulate the phase of incident electromagnetic wave from visible to microwave frequencies. Here, we present a reflective-type and high-efficiency meta-hologram fabricated by metasurface for visible wavelength. Using gold cross nanoantennas as building blocks to construct our meta-hologram devices with thickness ∼ λ/4, the reconstructed images of meta-hologram show polarization-controlled dual images with high contrast, functioning for both coherent and incoherent light sources within a broad spectral range and under a wide range of incidence angles. The flexibility demonstrated here for our meta-hologram paves the road to a wide range of applications related to holographic images at arbitrary electromagnetic wave region.
Selective Protein Adsorption on a Phase-Separated Solvent-Cast Polymer Blend (2006)

Polymer-based biomedical devices are growing increasingly sophisticated as compositions evolve toward copolymers and blends in order to satisfy complex design criteria. Such polymers afford opportunities for both micro- and macrophase separation at nano- and micro-length scales and raise questions concerning the role of heterogeneous surface morphology on protein adsorption. Adsorbed protein layers play a critical role in mediating the interaction of cells with polymer surfaces, and both understanding and controlling protein adsorption is assuming greater significance in the development of surfaces with enhanced physiological compatibility. Here we study the short-time adsorption of ferritin, a model protein highly resistant to denaturation and easily imaged in the transmission electron microscope (TEM), onto a phase-separated homopolymer blend of polycaprolactone (PCL) and a polycarbonate derived from desaminotyrosyl-tyrosine dodecyl ester (PDTD). At physiological pH, ferritin selectively adsorbs onto the PDTD phase at a surface density approximately three times greater than that on the PCL phase. By decreasing the pH below ferritin's isoelectric point so its average charge becomes positive, the selective adsorption disappears and the surface density of adsorbed ferritin becomes independent of the phase separation. We attribute the selectivity to the electrostatic repulsion between ferritin and hydrolytically charged PCL, both of which will have a net negative charge at physiological pH. To perform these experiments, we solvent-cast ultrathin polymer films onto dissolvable salt substrates, and we characterize the morphology by TEM imaging and quantitative spatially resolved electron energy-loss spectroscopy (EELS). We find that the film morphology depends strongly on such processing-related variables as the solvent evaporation rate and the nature of the surface in contact with the polymer film during casting. The adsorption of ferritin depends on whether the film is phase-separated as well as to which surface of the film the protein solution is exposed, and these findings suggest that seemingly small variations in polymer processing that influence both the bulk and surface morphology can have a profound effect on the short-time protein adsorption.
Baseband Linearity and Equalization in Fiber Optic Digital Communication Systems (1973)

If a sequence of digitally on-off modulated optical pulses is injected into a dielectric waveguide, these pulses may begin to overlap after a sufficient distance of propagation because of material dispersion and/or group delay spreading. In general, the pulses will not add linearly in power, which can complicate the problem of equalization of the square-law (power) detected overlapping output pulses at baseband. This paper illustrates important situations in which the guide may be treated as “pseudo-linear” in power, meaning that the detected guide output pulses appear to add linearly.
The retrovirus pol gene encodes a product required for DNA integration: identification of a retrovirus int locus. (1984)

We mutagenized cloned spleen necrosis virus DNA to identify a region of the retrovirus genome encoding a polypeptide required for integration of viral DNA. Five plasmids bearing different lesions in the 3' end of the pol gene were examined for the ability to integrate or replicate following transfection of chicken embryo fibroblasts. Transfection with one of these DNAs resulted in the generation of mutant virus incapable of integrating but able to replicate at low levels; this phenotype is identical to that of mutants bearing alterations in the cis-acting region, att. To determine whether the 3' end of the pol gene encodes a protein that interacts with att, we did a complementation experiment. Cells were first infected with an att- virus and then superinfected with the integration-deficient virus containing a lesion in the pol gene and a wild-type att site. The results showed that the att- virus provided a transacting function allowing integration of viral DNA derived from the mutant bearing a wild-type att site. Thus, the 3' end of the pol gene serves as an "int" locus and encodes a protein mediating integration of retrovirus DNA through interaction with att.
Cortical Potentials Evoked by Deep Brain Stimulation in the Subthalamic Area (2011)

Deep brain stimulation (DBS) of the subthalamic nucleus (STN) has been used since the mid-1990s as a treatment for patients with Parkinson's disease, and more recently also in other conditions, such as dystonia or obsessive compulsive disorder. Non-invasive studies of cortical evoked potentials (EPs) that follow individual STN-DBS stimuli has provided us with insights about the conduction of the DBS pulses to the cortex. Such EPs have multiple components of different latencies, making it possible to distinguish short-latency and long-latency responses (3-8 ms and 18-25 ms latency, respectively). The available evidence indicates that these short- and long-latency EPs correspond to conduction from the STN stimulation site to the cortical recording location via anti- and orthodromic pathways, respectively. In this review we survey the literature from recording studies in human patients treated with STN-DBS for Parkinson's disease and other conditions, as well as recent animal studies (including our own) that have begun to elucidate details of the pathways, frequency dependencies, and other features of EPs. In addition, we comment on the possible clinical utility of this knowledge.
Preliminary characterization of the tumor cell cytotoxin in tumor necrosis serum. (1981)

Abstract A quantitative in vitro assay is described for the cytotoxic activity in tumor necrosis serum. The assay, which is based on the ability of survivor cells to incorporate the dye neutral red, measures the volume test substance killing 50,000 mouse L-M cells with an accuracy of ±6%. It detects cytotoxic/cytostatic effects at dilutions of tumor necrosis serum as great as 1 part in 64,000. The activity appears to segregate upon purification into multiple size forms that share similar physicochemical properties. Cytotoxic activity is not inhibited by the protease inhibitors diisopropylfluorophosphate, phenylmethylsul-fonylfluoride, and bovine pancreatic trypsin inhibitor; however, 20% normal serum in the assay medium inhibits cytotoxicity 66%. The activity is inactivated by treatment with serine proteases, sodium periodate, and dithiothreitol. The activity is markedly pH labile, stable at 56°C, and inactivated at 70°C. Multiple forms fractionate on gel filtration in a m.w. range of 225,000 to 100,000. These forms migrate electrophoretically in the α-globulin region. Another form fractionates with an apparent size of 50,000 and migrates electrophoretically anodal to albumin. Different size fractions are partially purified such that the cytotoxic activity per volume exceeds the parent serum. Two fractions (m.w. 225,000 and 50,000) fail to induce in vivo tumor necrosis of an intradermal tumor implant. A fraction with an intermediate size (m.w. 160,000) induces in vivo tumor necrosis. We suggest the cytotoxic and the necrotizing activities in tumor necrosis serum may be distinct.
Somatostatin analogues suppress the inflammatory reaction in vivo. (1994)

Somatostatin (Sms) and its agonist analogues inhibit the secretory activities of endocrine and neural cells. Recent studies have suggested that Sms has significant immunomodulatory properties. In this study, we examine the effects of two Sms octapeptide analogues on the inflammatory reaction in vivo. BIM 23014 (Somatulin) and Sandostatin were administered to male Sprague-Dawley rats subject to carrageenin-induced aseptic inflammation, at doses of 2-10 micrograms/rat, given either systemically or locally. Animals were killed 7 h after the induction of the inflammation, and the inflammatory exudates were aspirated and quantitated in terms of volume and leukocyte concentration. Sms analogues, administered via either route, significantly reduced the volume and the leukocyte concentration of the exudate in a time- and dose-dependent fashion. In corroboration of these, immunohistochemical evaluation of the levels of local inflammatory mediators, such as immunoreactive (Ir) TNF-alpha, Irsubstance P, and Ircorticotropin-releasing hormone, was inhibited significantly by Sms analogue treatment. These findings suggest that Sms analogues have significant antiinflammatory effects in vivo, associated with suppression of proinflammatory cytokines and neuropeptides. Furthermore, these data suggest that Sms agonists may be useful in the control of inflammatory reaction.
Nonreductive Desulfenylation of 3-Indolyl Sulfides. Improved Syntheses of 2-Substituted Indoles and 2-Indolyl Sulfides (1994)

ADVERTISEMENT RETURN TO ISSUEPREVArticleNEXTNonreductive Desulfenylation of 3-Indolyl Sulfides. Improved Syntheses of 2-Substituted Indoles and 2-Indolyl SulfidesPierre Hamel, Nicolas Zajac, Joseph G. Atkinson, and Yves GirardCite this: J. Org. Chem. 1994, 59, 21, 6372–6377Publication Date (Print):October 1, 1994Publication History Published online1 May 2002Published inissue 1 October 1994https://pubs.acs.org/doi/10.1021/jo00100a045https://doi.org/10.1021/jo00100a045research-articleACS PublicationsRequest reuse permissionsArticle Views995Altmetric-Citations25LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail Other access optionsGet e-Alertsclose Get e-Alerts
Papillary Thyroid Carcinoma and Inflammation (2011)

ORIGINAL RESEARCH article Front. Endocrinol., 16 December 2011 | https://doi.org/10.3389/fendo.2011.00088
Dilation of normal and constriction of atherosclerotic coronary arteries caused by the cold pressor test. (1988)

Increased vascular constriction has been observed at the site of atherosclerotic lesions, suggesting an association between atherosclerosis and altered vascular tone. While atherosclerosis may increase sensitivity to exogenous vasoconstrictors, little is known about the response of normal and atherosclerotic coronary arteries to an exogenous stimulus that excites the sympathetic nervous system. Therefore, we studied the response to cold pressor test (CPT) using quantitative angiography and Doppler flow velocity measurements in eight patients with angiographically normal coronary arteries (group I), nine patients with mild coronary atherosclerosis (less than 50% diameter narrowing) (group II), and 13 patients with advanced coronary stenoses (greater than 50% diameter narrowing) (group III). In 31 segments of angiographically smooth arteries in group I, the CPT produced vasodilation from a control mean diameter of 2.68 +/- 0.09 (mean +/- SE) to 2.99 +/- 0.09 mm at peak CPT (p less than 0.001), a 12 +/- 1% increase in diameter. In group II, 27 irregular segments constricted to peak CPT from a mean control diameter of 1.82 +/- 0.12 to 1.66 +/- 0.12 mm (p less than .001), a 9 +/- 1% decrease, while 10 smooth segments dilated from a mean control diameter of 1.98 +/- 0.11 mm to 2.34 +/- 0.15 mm (p less than .01), a 19 +/- 2% increase in diameter. Likewise, in group III, the 17 stenotic segments constricted from 1.16 +/- 0.09 to 0.89 +/- 0.09 mm (p less than .001), a 24 +/- 6% decrease; the irregular segments also constricted from 2.44 +/- 0.11 to 2.22 +/- 0.12 mm (p = .002), a 10 +/- 2% decrease. In contrast, two smooth segments dilated from 2.98 to 3.23 mm (mean), an 8% increase in diameter. Coronary blood flow increased 65 +/- 4% (mean) during CPT in group I, it increased 15 +/- 6% in group II, and it decreased 39 +/- 8% in group III. The vasodilator response in four normal patients was partly inhibited by the administration of intracoronary propranolol (17 +/- 3% increase during control, 10 +/- 2% increase after propranolol, 41% less dilation; p = .002). We conclude that the response of normal coronary arteries to the CPT test is dilation, in part related to beta-adrenoreceptor stimulation and possibly flow-mediated endothelial dilation or alpha 2-adrenergic activity. The paradoxical vasoconstrictor response induced by atherosclerosis may represent altered catecholamine sensitivity and/or a defect in endothelial vasodilator function. The presence of atherosclerosis impairs vasodilator responses and thus may contribute to the pathogenesis of myocardial ischemia.
Notch and Kras reprogram pancreatic acinar cells to ductal intraepithelial neoplasia (2008)

Efforts to model pancreatic cancer in mice have focused on mimicking genetic changes found in the human disease, particularly the activating KRAS mutations that occur in pancreatic tumors and their putative precursors, pancreatic intraepithelial neoplasia (PanIN). Although activated mouse Kras mutations induce PanIN lesions similar to those of human, only a small minority of cells that express mutant Kras go on to form PanINs. The basis for this selective response is unknown, and it is similarly unknown what cell types in the mature pancreas actually contribute to PanINs. One clue comes from the fact that PanINs, unlike most cells in the adult pancreas, exhibit active Notch signaling. We hypothesize that Notch, which inhibits differentiation in the embryonic pancreas, contributes to PanIN formation by abrogating the normal differentiation program of tumor-initiating cells. Through conditional expression in the mouse pancreas, we find dramatic synergy between activated Notch and Kras in inducing PanIN formation. Furthermore, we find that Kras activation in mature acinar cells induces PanIN lesions identical to those seen upon ubiquitous Kras activation, and that Notch promotes both initiation and dysplastic progression of these acinar-derived PanINs, albeit short of invasive adenocarcinoma. At the cellular level, Notch/Kras coactivation promotes rapid reprogramming of acinar cells to a duct-like phenotype, providing an explanation for how a characteristically ductal tumor can arise from nonductal acinar cells.
Abnormal Expressions of a Serine Protease in Human Dystrophic Muscle1 (1978)

The activities of serine protease in muscles from normal persons and from patients with progressive muscular and neuromuscular diseases have been determined. A significant increase in the level of serine protease was found in muscle of patients with Duchenne-type muscular dystrophy and with Becker-type muscular dystrophy, but the activity was not increased in muscle of a patient with amyotrophic lateral sclerosis.
Three-dimensional resistivity and switching between correlated electronic states in 1T-TaS2 (2017)

Recent demonstrations of controlled switching between different ordered macroscopic states by impulsive electromagnetic perturbations in complex materials have opened some fundamental questions on the mechanisms responsible for such remarkable behavior. Here we experimentally address the question of whether two-dimensional (2D) Mott physics can be responsible for unusual switching between states of different electronic order in the layered dichalcogenide 1T-TaS<sub>2</sub>, or it is a result of subtle inter-layer "orbitronic" re-ordering of its stacking structure. We report on in-plane (IP) and out-of-plane (OP) resistance switching by current-pulse injection at low temperatures. Elucidating the controversial theoretical predictions, we also report on measurements of the anisotropy of the electrical resistivity below room temperature. From the T-dependence of ρ<sub>⊥</sub> and ρ<sub>||</sub>, we surmise that the resistivity is more consistent with collective motion than single particle diffusive or band-like transport. The relaxation dynamics of the metastable state for both IP and OP electron transport are seemingly governed by the same mesoscopic quantum re-ordering process. We conclude that 1T-TaS<sub>2</sub> shows resistance switching arising from an interplay of both IP and OP correlations.
FPGAs for trusted cloud computing (2012)

FPGA manufacturers have offered devices with bitstream protection for a number of years. This feature is currently primarily used to prevent IP piracy through cloning. However, in this paper we describe how protected bitstreams can also be used to create a root of trust for the clients of cloud computing services. Unlike related software-based solutions, this hardware-based approach solves a fundamental problem that currently impedes the greater adoption of cloud computing: how to secure client data and computation from both potential external attackers and an untrusted system administrator. We examine how this approach can be applied to the specific application of handling sensitive health data. This system maintains the advantages of the cloud with minimal additional hardware. We also describe how this system can be extended to provide a more generic secure cloud architecture.
Pulmonary arterial remodeling induced by a Th2 immune response (2008)

Pulmonary arterial remodeling characterized by increased vascular smooth muscle density is a common lesion seen in pulmonary arterial hypertension (PAH), a deadly condition. Clinical correlation studies have suggested an immune pathogenesis of pulmonary arterial remodeling, but experimental proof has been lacking. We show that immunization and prolonged intermittent challenge via the airways with either of two different soluble antigens induced severe muscularization in small- to medium-sized pulmonary arteries. Depletion of CD4(+) T cells, antigen-specific T helper type 2 (Th2) response, or the pathogenic Th2 cytokine interleukin 13 significantly ameliorated pulmonary arterial muscularization. The severity of pulmonary arterial muscularization was associated with increased numbers of epithelial cells and macrophages that expressed a smooth muscle cell mitogen, resistin-like molecule alpha, but surprisingly, there was no correlation with pulmonary hypertension. Our data are the first to provide experimental proof that the adaptive immune response to a soluble antigen is sufficient to cause severe pulmonary arterial muscularization, and support the clinical observations in pediatric patients and in companion animals that muscularization represents one of several injurious events to the pulmonary artery that may collectively contribute to PAH.